Recall
FDAHealthJuly 30, 2025

Cardinal Health Inc. — Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.

⚠️ CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 30, 2025

Nationwide Within the U.S.

What's affected?

Product
Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.
Brand
XOLAIR
Lot code
3617756

Additional details

Lot: 3617756, Expires: 12/31/2025.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 6 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.